Filing Details
- Accession Number:
- 0001110803-14-000143
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-16 20:36:54
- Reporting Period:
- 2014-04-15
- Filing Date:
- 2014-04-16
- Accepted Time:
- 2014-04-16 20:36:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534166 | Nicholas Naclerio | 5200 Illumina Way San Diego CA 92122 | Sr Vp, Corp Develop & Gm | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-15 | 2,000 | $43.37 | 25,146 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-15 | 484 | $132.47 | 24,662 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-15 | 1,016 | $133.39 | 23,646 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-15 | 300 | $134.55 | 23,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-15 | 200 | $135.56 | 23,146 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-04-15 | 2,000 | $0.00 | 2,000 | $43.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 76,000 | 2011-08-08 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 484 shares sold ranging from $131.86 to $132.70 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,016 shares sold ranging from $132.99 to $133.70 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $134.38 to $134.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $135.5436 to $135.58 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
